BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10353384)

  • 21. Selective mutation of K-ras by N-ethylnitrosourea shifts from codon 12 to codon 61 during fetal mouse lung maturation.
    Sithanandam G; Ramakrishna G; Diwan BA; Anderson LM
    Oncogene; 1998 Jul; 17(4):493-502. PubMed ID: 9696043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of Ras mutations in rat DMBA-induced mammary tumors.
    Samuelson E; Nilsson J; Walentinsson A; Szpirer C; Behboudi A
    Mol Carcinog; 2009 Feb; 48(2):150-5. PubMed ID: 18649354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vinyl chloride-specific mutations in humans and animals.
    Marion MJ; Boivin-Angele S
    IARC Sci Publ; 1999; (150):315-24. PubMed ID: 10626231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues.
    Schmeiser HH; Janssen JW; Lyons J; Scherf HR; Pfau W; Buchmann A; Bartram CR; Wiessler M
    Cancer Res; 1990 Sep; 50(17):5464-9. PubMed ID: 2201437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.
    Kumar R; Angelini S; Hemminki K
    Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of K-ras mutations in azoxymethane-induced aberrant crypt foci in mice using LNA-mediated real-time PCR clamping and mutant-specific probes.
    Hu Y; Le Leu RK; Young GP
    Mutat Res; 2009; 677(1-2):27-32. PubMed ID: 19442760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke.
    Yao R; Wang Y; D'Agostini F; Izzotti A; Lubet RA; You M; De Flora S
    Exp Lung Res; 2005 Mar; 31(2):271-81. PubMed ID: 15824025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated real-time PCR to determine K-ras codon 12 mutations in non-small cell lung cancer: comparison with immunohistochemistry and clinico-pathological features.
    Hilbe W; Dlaska M; Duba HC; Dirnhofer S; Eisterer W; Oberwasserlechner F; Mildner A; Schmid T; Kühr T; Wöll E
    Int J Oncol; 2003 Oct; 23(4):1121-6. PubMed ID: 12963994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. K-ras codon 12 and 61 point mutations in bromodeoxyuridine- and N-nitrosomethylurea-induced rat renal mesenchymal tumors.
    Calvert RJ; Buzard GS; Anisimov VN; Rice JM
    Cancer Lett; 1996 Dec; 109(1-2):1-7. PubMed ID: 9020896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study.
    Slattery ML; Curtin K; Anderson K; Ma KN; Edwards S; Leppert M; Potter J; Schaffer D; Samowitz WS
    Cancer Res; 2000 Dec; 60(24):6935-41. PubMed ID: 11156393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
    Hu W; Feng Z; Tang MS
    Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf.
    Wang Y; Zhang Z; Lubet R; You M
    Oncogene; 2005 Apr; 24(18):3042-9. PubMed ID: 15846305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 and K-ras mutations in lung cancers from former and never-smoking women.
    Vähäkangas KH; Bennett WP; Castrén K; Welsh JA; Khan MA; Blömeke B; Alavanja MC; Harris CC
    Cancer Res; 2001 Jun; 61(11):4350-6. PubMed ID: 11389059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution.
    Soliman AS; Lo AC; Banerjee M; El-Ghawalby N; Khaled HM; Bayoumi S; Seifeldin IA; Abdel-Aziz A; Abbruzzese JL; Greenson JK; Hamilton SR
    Carcinogenesis; 2007 Aug; 28(8):1794-9. PubMed ID: 17575320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
    Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
    J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways.
    Lax SF; Kendall B; Tashiro H; Slebos RJ; Hedrick L
    Cancer; 2000 Feb; 88(4):814-24. PubMed ID: 10679651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of H-ras is prevalent in 1,3-butadiene-induced and spontaneously occurring murine Harderian gland tumors.
    Goodrow TL; Nichols WW; Storer RD; Anderson MW; Maronpot RR
    Carcinogenesis; 1994 Nov; 15(11):2665-7. PubMed ID: 7955123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
    Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
    Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.